Adverse events326

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 326

Download this page as JSON

Type	Event	Organ system	Group	Affected	At risk
other	Anaemia	Blood and lymphatic system disorders	MCI-196 (Active) + Simvastatin (Placebo)/ Comparison Phase	11	128
other	Anaemia	Blood and lymphatic system disorders	Simvastatin (Active) + MCI-196 (Placebo)/ Comparion Phase	12	131
other	Anaemia vitamin B12 deficiency	Blood and lymphatic system disorders	MCI-196 (Active) + Simvastatin (Placebo)/ Comparison Phase	1	128
other	Anaemia vitamin B12 deficiency	Blood and lymphatic system disorders	Simvastatin (Active) + MCI-196 (Placebo)/ Comparion Phase	0	131
other	Leukocytosis	Blood and lymphatic system disorders	MCI-196 (Active) + Simvastatin (Placebo)/ Comparison Phase	1	128
other	Leukocytosis	Blood and lymphatic system disorders	Simvastatin (Active) + MCI-196 (Placebo)/ Comparion Phase	0	131
other	Nephrogenic anaemia	Blood and lymphatic system disorders	MCI-196 (Active) + Simvastatin (Placebo)/ Comparison Phase	1	128
other	Nephrogenic anaemia	Blood and lymphatic system disorders	Simvastatin (Active) + MCI-196 (Placebo)/ Comparion Phase	0	131
other	Angina pectoris	Cardiac disorders	MCI-196 (Active) + Simvastatin (Placebo)/ Comparison Phase	1	128
other	Angina pectoris	Cardiac disorders	Simvastatin (Active) + MCI-196 (Placebo)/ Comparion Phase	0	131
other	Angina unstable	Cardiac disorders	MCI-196 (Active) + Simvastatin (Placebo)/ Comparison Phase	1	128
other	Angina unstable	Cardiac disorders	Simvastatin (Active) + MCI-196 (Placebo)/ Comparion Phase	0	131
other	Aortic valve calcification	Cardiac disorders	MCI-196 (Active) + Simvastatin (Placebo)/ Comparison Phase	1	128
other	Aortic valve calcification	Cardiac disorders	Simvastatin (Active) + MCI-196 (Placebo)/ Comparion Phase	0	131
other	Atrioventricular block second degree	Cardiac disorders	MCI-196 (Active) + Simvastatin (Placebo)/ Comparison Phase	1	128
other	Atrioventricular block second degree	Cardiac disorders	Simvastatin (Active) + MCI-196 (Placebo)/ Comparion Phase	0	131
other	Bradycardia	Cardiac disorders	MCI-196 (Active) + Simvastatin (Placebo)/ Comparison Phase	0	128
other	Bradycardia	Cardiac disorders	Simvastatin (Active) + MCI-196 (Placebo)/ Comparion Phase	1	131
other	Coronary artery stenosis	Cardiac disorders	MCI-196 (Active) + Simvastatin (Placebo)/ Comparison Phase	1	128
other	Coronary artery stenosis	Cardiac disorders	Simvastatin (Active) + MCI-196 (Placebo)/ Comparion Phase	0	131

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00858637/events

API reference For AI assistants

Adverse events326

Sources 3

Read this list from software.